1. Sung, H, Ferlay, J, Siegel, RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;70:1-41.
Google Scholar2. Di Francesco, AM, Ruggiero, A, Riccardi, R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci. 2002;59:1914-1927.
Google Scholar | Crossref | Medline3. DiFrancia, R, Siesto, RS, Valente, D, et al. Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests. Anticancer Drugs. 2013;24:1069-1078.
Google Scholar | Crossref | Medline4. Tournigand, C, Cervantes, A, Figer, A, et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer: a GERCOR study. J Clin Oncol. 2006;24:394-400.
Google Scholar | Crossref | Medline | ISI5. Cassidy, J, Clarke, S, Díaz-Rubio, E, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol. 2008;26:2006-2012.
Google Scholar | Crossref | Medline | ISI6. Lu, X, Zheng, Y, Wen, F, Huang, W, Shu, P. Effectiveness and safety of oral Chinese patent medicines combined with chemotherapy for gastric cancer: a Bayesian network meta-analysis. Evid Based Complement Alternat Med. 2020;2020:1-16.
Google Scholar7. Yu, D, An, GY. Clinical effects of Xihuang pill combined with chemotherapy in patients with advanced colorectal cancer. Evid Based Complement Alternat Med. 2017;2017:5936086.
Google Scholar | Crossref | Medline8. Xu, H, Wei, W, Y, M, Dong, C. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Biosci Rep. 2020;40:BSR20194019.
Google Scholar | Crossref9. Tonin, FS, Rotta, I, Mendes, AM, Pontarolo, R. Network meta-analysis: a technique to gather evidence from direct and indirect comparisons. Pharm Pract. 2017;15:943.
Google Scholar | Crossref | Medline10. Li, W, Guo, J, Wang, Q, Tang, J, You, F. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a protocol for systematic review of randomized controlled trials. Medicine. 2020;99:e23216.
Google Scholar | Crossref | Medline11. Zhang, D, Wu, J, Duan, X, et al. Network meta-analysis of Chinese herbal injections plus the FOLFOX regimen for the treatment of colorectal cancer in China. Integr Cancer Ther. 2019;18:1-18.
Google Scholar | SAGE Journals12. Therasse, P, Arbuck, SG, Eisenhauer, EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
Google Scholar | Crossref | Medline13. The Cochrane Collaboration . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Cochrane; 2011. http://www.cochrane.org/training/cochrane-handbook
Google Scholar14. Nikolakopoulou, A, Higgins, JPT, Papakonstantinou, T, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17:e1003082.
Google Scholar | Crossref | Medline15. Greco, T, Edefonti, V, Biondi-Zoccai, G, et al. A multilevel approach to network meta-analysis within a frequentist framework. Contemp Clin Trials. 2015;42:51-59.
Google Scholar | Crossref | Medline16. Salanti, G, Ades, AE, Ioannidis, JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163-171.
Google Scholar | Crossref | Medline | ISI17. Higgins, JP, Jackson, D, Barrett, JK, Lu, G, Ades, AE, White, IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3:98-110.
Google Scholar | Crossref | Medline | ISI18. Chaimani, A, Higgins, JP, Mavridis, D, Spyridonos, P, Salanti, G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8:e76654.
Google Scholar | Crossref | Medline | ISI19. Quan, B . Observation on the efficacy of Sinopatidine capsule combined with chemotherapy in the treatment of rectal cancer. J N Chin Med. 2016;48:197-199.
Google Scholar20. Zhou, H, Zhang, L, Tian, GY, et al. Evaluation of the efficacy of Sinopaquin capsule in the adjuvant treatment of advanced colorectal cancer. Chin J Rural Med Pharm. 2014;21:9-10.
Google Scholar21. Chang, ZG . Sinopatidine capsules in combination with FOLFOX4 regimen treatment of advanced colon cancer. Pract Clin Med. 2019;120:28-29.
Google Scholar22. Dong, L, Li, H, Li, G, et al. Clinical observation on the efficacy of Sinopaquin capsule combined with XELOX in the treatment of advanced colorectal cancer. Strait Pharm J. 2017;29:169-171.
Google Scholar23. Dong, M . Observation on the clinical efficacy of Cinobufotalin combined with chemotherapy in the treatment of advanced colon cancer. Chin Community Doctors. 2018;34:27-28.
Google Scholar24. Lu, G, Lu, X, Zhao, Q, et al. A clinical study of 30 patients with advanced colorectal cancer treated with Sinopaquin capsule combined with chemotherapy. Med J Commun. 2014;28:647-651.
Google Scholar25. Shi, YJ, Li, Y, Zhao, N. Efficacy of Cinobufacini capsule combined with chemotherapy for stage III colorectal carcinoma after surgery. Chin J Clin Oncol Rehabil. 2017;24:1078-1081.
Google Scholar26. Li, F, Li, N. Clinical effect of Cinobufacin capsule combined oxaliplatin and S-1 for advanced colorectal cancer. Clin J Med Offic. 2016;44:1033-1036.
Google Scholar27. Liu, JP, Jiang, J, Wei, H, et al. Clinical effect of Cinobufotalin capsule combined with XELOX chemotherapy on treatment of advanced colorectal cancer. Med J West China. 2017;29:1560-1563.
Google Scholar28. Xing, HJ, Zhang, HS, Hou, L, et al. Clinical observation of compound blister beetle capsule combined with chemotherapy for patients after radical resection of rectal cancer. Liaoning J Tradit Chin Med. 2017;44:1431-1433.
Google Scholar29. Hu, ZK, Li, W, Su, CZ, et al. Clinical efficacy of compound Banmao capsule combined with chemotherapy in patients with rectal cancer after radical resection. Med Pract. 2019;14:80-83.
Google Scholar30. Bai, Y, Hu, L. Clinical observation of the effect of compound cantharis capsule combined with chemotherapy in the treatment of metastatic colorectal cancer. Med J West China. 2013;25:1017-1019.
Google Scholar31. Zhao, WY, Cheng, YF. The efficacy of Fufangbanmao capsules combined with chemotherapy in the treatment of patients with metastatic colorectal cancer. Chin J Dig. 2010;30:452-455.
Google Scholar32. Cao, GC, Bai, JJ, Qi, WH, et al. Clinical study on compound Banmao capsules combined with FOLFOX6 chemotherapy in treatment of elderly hepatic metastasis of colonic carcinoma. Drug Clin. 2017;32:1759-1763.
Google Scholar33. Qin, DL, Song, YF. Clinical analysis of Boerning capsule combined with FOLFOX4 in the treatment of colon cancer. Guide Chin Med. 2013;11:214-215.
Google Scholar34. Xie, JB, Jia, CH, Yuan, Y, et al. Clinical efficacy of Boerning capsules plus XELOX regimen in treatment of colorectal cancer. World Chin J Dig. 2017;25:1110-1114.
Google Scholar | Crossref35. Li, HT . Clinical observation of Xihuang pill combined with chemotherapy in the treatment of colorectal cancer. Res Integr Tradit Chin West Med. 2017;9:299-300.
Google Scholar | Crossref36. Zeng, DX, Ling, Y, Ql, Y, et al. Ginsenoside Rg3 capsules combined with FOLFOX4 regimen for treatment of advanced colon Cancer: a report of 35 cases. J Bengbu Med Coll. 2009;34:1092-1094.
Google Scholar37. Lou, CS . Clinical observation of Shenyi capsule combined with FOLFOX6 chemotherapy for postoperative adjuvant therapy of colorectal cancer. Strait Pharma J. 2010;22:174-175.
Google Scholar38. Gai, L, Shi, B, Zhang, XB. Clinical observation of Shenyi capsule combined with XELOX and XELOX alone in the treatment of advanced rectal cancer. Mod J Integr Tradit Chin West Med. 2010;19:1066-1167.
Google Scholar39. Wang, YS, Wang, YT. Treatment of advanced colorectal carcinoma by Shenyi capsule and XELOX regimen in elders. Oncol Prog. 2011;9:438-440.
Google Scholar40. Cao, J, Chu, J, Zhou, J, et al. Effect and safety evaluation of Shenyi capsule on chemotherapy for advanced colorectal cancer. World Clin Med. 2016;10:29-30.
Google Scholar41. Ji, XH, Zhang, Y. Affect of Shenyi capsule for later period colorectal cancer chemotherapy. Med Inf. 2011;24:4983-4984.
Google Scholar42. Xiang, M, Wei, XL. Clinical study of Pingxiao capsules combined with FOLFOX4 scheme in treatment of colorectal cancer. Drug Clin. 2015;30:700-705.
Google Scholar43. Xu, GS . Xiaoaiping tablets combined with chemotherapy on advanced colorectal cancer. Chin Arch Tradit Chin Med. 2016;34:1527-1529.
Google Scholar44. Yang, ZH, Wu, M, Liu, R, et al. Clinical observation of Jin Long capsule Chemotherapy on late cancer of colon. Mod Med J. 2013;41(12):908-910.
Google Scholar45. Zhu, LM, Zhou, XY. The clinical research of Jinlong capsule combined with chemotherapy on advanced colon cancer. J Shanxi Coll Tradit Chin Med. 2013;14:45-47.
Google Scholar46. Zhang, PY, Pei, JW. The clinical research of Jin Long capsule combined chemotherapy on middle and late cancer of colon. Chin J Chin Med. 2010;25(1):398-399.
Google Scholar47. Tang, H, Zhao, HX. Clinical observation of Antioch capsule combined with chemotherapy for advanced colon cancer. Health. 2013;7:87-88.
Google Scholar48. Wang, M, Yang, Y, Li, C, et al. Clinical study on Antike capsules combined with capecitabine and oxaliplatin in treatment of advanced colorectal cancer. Drug Clin. 2016;31:1036-1039.
Google Scholar49. Fang, Q, Xu, HG, Shao, CF, et al. Clinical study of Kangaiping Wan on postoperative patients with colorectal cancer treated with FOLFOX chemotherapy. Chin J Biochem Pharm. 2017;37(2):93-96.
Google Scholar50. Wang, SW, Xie, YH, Zhu, LZ. Mechanism of anti-tumor effect of Antike capsule. J Fourth Milit Med Univ. 1997;12:119-120.
Google Scholar51. Duan, L, Li, H, Yuan, J, et al. Fingerprint analysis and quantitative determination of 16 constituents of Antike capsule by high-performance liquid chromatography-photodiode array detection. Anal Methods. 2015;7:6695-6704.
Google Scholar | Crossref52. Mingwen, S, Jinrong, Q, Hao, W, et al. Mechanism of Shenyi capsule concomitant with Endostar and chemotherapy on the growth and apoptosis of MCF-7 breast cancer cells. J Int Transl Med. 2014;2:299-302.
Google Scholar53. Pan, L, Zhang, T, Sun, H, Liu, G. Ginsenoside Rg3 (Shenyi capsule) combined with chemotherapy for digestive system cancer in China: a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2019;2019:2417418.
Google Scholar | Crossref | Medline54. Hu, Z, Qian, W, Dong, L. Experimental study of antitumor effect of Kang’aiping granule in vivo and in vitro. Acta Universitatis Medicinalis Anhui. 2011;46:245-248.
Google Scholar55. Zhang, JF . Effects of Kang’aiping pills combined with TACE in treatment of 30 cases of advanced liver cancer. Chongqing Med. 2010;39:563-564.
Google Scholar56. Li, D, Ni, T, Tao, L, et al. Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro. Biomed Pharmacother. 2018;107:738-745.
Google Scholar | Crossref | Medline57. Xu, FQ, Zhang, XR, Guo, FW, et al. Research progress on the quality control of Chinese patent medicine. Prog Mod Biomed. 2014;14:6159-6163.
Google Scholar58. Liang, SW . Analysis of Chinese Pharmaceutical Preparation. China Press of Traditional Chinese Medicine; 2003:1-2.
Google Scholar